Short answer
Innoviva, Inc. (INVA) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Derek Small and Mark DiPaolo resigned May 12 to focus on Syndeio BioSciences, where Innoviva has invested and expects continued support.
Innoviva, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Derek Small and Mark DiPaolo resigned May 12 to focus on Syndeio BioSciences, where Innoviva has invested and expects continued support
- Departures unrelated to disagreements, reducing concern over governance or strategy disputes
- Josephine Linden elected May 18 as an independent director, strengthening investment-management and public-company governance expertise
- Expected Audit Committee appointment adds experienced financial oversight
- Director compensation includes $125,000 initial RSUs, $206,250 prorated RSUs, and options for 9,166 shares
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Innoviva, Inc. 8-K filings
Get the next INVA 8-K as it lands
Follow INVA for push alerts, or ask the research agent what this filing means.